Bruker and Charles River Ink Deal to Link MALDI Biotyper and Accugenix Database | GenomeWeb

Bruker and Charles River said this week they have agreed to a partnership deal under which they will sell Bruker's MALDI Biotyper system packaged with access to Charles River's cGMP-compliant Accugenix microbial database.

Called the Axcess System, the new product is aimed at environmental monitoring applications and will allow Biotyper customers to "have access to the most current and validated database for identifications, saving time and costs associated with validating library releases," the companies said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.